Close Window
SCIENCE IDENTITY DEVELOPMENT FOR PHASE I
- Androgogy/insight-mining market research and competitive analyses
- Target product profiling and novel endpoint/clinical trial protocol elucidation
- Preliminary lexicon development
- Preliminary science STORY™, scientific statements, and lexicon development
- Generic name development and/or unique class descriptor development
- Disease state and mechanism of action elucidation and visualizations
- Exhibits, posters, and interactive experiences
SCIENCE IDENTITY DEVELOPMENT FOR PHASE II
- Androgogy/insight-mining market research and competitive analyses
- Target product profiling and novel endpoint/clinical trial protocol elucidation
- Science identity development (positioning, archetype, value proposition)
- Science STORY™, scientific statements, and lexicon development
- Generic name development and/or unique class descriptor development
- Disease state and mechanism of action elucidation and visualizations
- Science identity strategic brief
- Scientific identity guidelines and standards (pre-launch)
- Exhibits, posters, and interactive experiences
PRODUCT IDENTITY DEVELOPMENT FOR PHASE III
- Androgogy/insight-mining market research and competitive analyses
- Brand identity development (positioning, archetype, value proposition)
- Brand identity strategy and brand identity strategic brief development
- Brand STORY™, messaging, and lexicon development
- Design system
- Brand identity guidelines and standards (Brand Book)
- Specialty pharma communications programs, including monographs
- Exhibits, posters, and interactive experiences
- Brand training
BRAND IDENTITY MANAGEMENT POST-LAUNCH
- Brand portfolio/franchise strategy and architecture development
- Transitional brand development (for additional indications)
- Specialty pharma communications programs
- Brand image perceptual research tracking
- Exhibits, posters, and interactive experiences
- Brand stewardship